نتایج جستجو برای: dolutegravir

تعداد نتایج: 953  

Journal: :Reactions Weekly 2021

2016
Vici Varghese Benjamin A. Pinsky Darvin S. Smith Daniel Klein Robert W. Shafer

The integrase strand transfer inhibitor (INSTI)-resistance mutations Q148H/K/R are arguably the most important INSTI-resistance mutations as they represented the first step to high-level dolutegravir cross-resistance. We describe an individual with transmitted four-class drug resistance whose virus sequence had the previously uncharacterized mutation Q148N. Infectious molecular HIV-1 clones con...

Journal: :American family physician 2000
M Preboth

ABACAVIR+LAMIVUDINE+ZIDOVUDINE (TRIZIVIR, TZV) ABACAVIR+DOLUTEGRAVIR+LAMIVUDINE (TRIUMEQ, TRI) ADEFOVIR DIPIVOXIL (HEPSERA, ADV) AMPRENAVIR (AGENERASE, APV) (AGENERASE NO LONGER MANUFACTURED AS OF 2007) ATAZANAVIR (REYATAZ, ATV) ATAZANAVIR+COBICISTAT (EVOTAZ, EVO) COBICISTAT (TYBOST, COBI) DARUNAVIR (PREZISTA, DRV) DARUNAVIR+COBICISTAT (PREZCOBIXTM, REZOLSTATM, PCX) DELAVIRDINE MESYLATE (RESCRI...

2014

Mechanism of Action: Dolutegravir inhibits the catalytic activity of HIV integrase, which is an HIV encoded enzyme required for viral replication. Integrase is one of the three HIV-1 enzymes required for viral replication. Integration of HIV into cellular DNA is a multi-step process. First, the assembly of integrase in a stable complex with the viral DNA occurs. Second, the terminal dinucleotid...

Journal: :The lancet. HIV 2017
Paul E Sax Edwin DeJesus Gordon Crofoot Douglas Ward Paul Benson Robin Dretler Anthony Mills Cynthia Brinson Julie Peloquin Xuelian Wei Kirsten White Andrew Cheng Hal Martin Erin Quirk

BACKGROUND All recent treatment guidelines recommend integrase strand transfer inhibitors (INSTIs) as components of initial HIV therapy. Bictegravir, a novel, once-daily, unboosted INSTI, showed potent activity in a 10 day monotherapy study and has a high in-vitro resistance barrier. On the basis of these results, we did a phase 2 trial comparing bictegravir with dolutegravir. METHODS In this...

2017
R. Montejano N. Stella-Ascariz S. Garcia-Bujalance E. Valencia J. González JR. Arribas

2014
A Wong

Laboratory interactions (Quality of Evidence: high; no clinical significance) • Cobicistat (Stribild®, Tybost®), rilpivirine (Edurant®, Complera®) and dolutegravir (Tivicay®) containing regimens will increase serum creatinine by approximately 7-15 μmol/L during the first 4 weeks of treatment initiation due to inhibition of renal creatinine secretion. This does not reflect an actual decrease in ...

Journal: :The journal of physical chemistry. B 2009
Mauro C C Ribeiro Tullio Scopigno Giancarlo Ruocco

The pressure dependence of the glass-transition temperature, Tg(P), of the ionic glass-former 2Ca(NO3)2 x 3KNO3, CKN, has been obtained by molecular dynamics (MD) simulations The liquid-glass difference of thermal expansivity, deltaalpha, heat capacity, deltaCp, and isothermal compressibility, deltak, have been calculated as a function of pressure. It has been found that the Ehrenfest relation ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید